On the agenda - NICE rejects liver cancer treatment

In a nutshell The National Institute for Health and Clinical Excellence has come under fire for denying NHS funding for its primary liver cancer treatment. The government drug rationing body rejected the drug on the grounds that it was not a cost-effective use of NHS resources.